aristolochic acid i has been researched along with Angiosarcoma in 1 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Notably, ESRD-associated HAS had a significantly higher TMB (17." | 1.91 | Association between hepatic angiosarcoma and end-stage renal disease: nationwide population-based evidence and enriched mutational signature of aristolochic acid exposure. ( Chang, CJ; Chang, IY; Chen, CC; Chen, KH; Chen, TC; Chuang, HC; Hsieh, TY; Huang, HY; Huang, SC; Lin, IC; Liu, H; Liu, TT; Ng, KF, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, SC | 1 |
| Chang, IY | 1 |
| Chang, CJ | 1 |
| Liu, H | 1 |
| Chen, KH | 1 |
| Liu, TT | 1 |
| Hsieh, TY | 1 |
| Chuang, HC | 1 |
| Chen, CC | 1 |
| Lin, IC | 1 |
| Ng, KF | 1 |
| Huang, HY | 1 |
| Chen, TC | 1 |
1 other study available for aristolochic acid i and Angiosarcoma
| Article | Year |
|---|---|
Association between hepatic angiosarcoma and end-stage renal disease: nationwide population-based evidence and enriched mutational signature of aristolochic acid exposure.
Topics: Hemangiosarcoma; Humans; Incidence; Kidney Failure, Chronic; Liver Neoplasms; Mutation; Renal Insuff | 2023 |